← Back to catalogue

SpiroSphere, SpiroSphereECG, CardioSphere

FDA 510(k)EUDAMED

Class II (US FDA 510(k))

510(k) K223629

by eResearchTechnology GmbH

Identifiers

510(k) Number
K223629 FDA 510(k)
FDA Product Code
BTY FDA 510(k)

Classification

Device Class
Class II FDA 510(k)
Legislation / Framework
21 CFR Part 868.1890 FDA 510(k)
Regulation Number
868.1890 FDA 510(k)
Advisory Committee
Anesthesiology FDA 510(k)
FDA Decision
SESE Substantially Equivalent FDA 510(k)

The SpiroSphere, SpiroSphereECG, and CardioSphere are Pulmonary Function Calculators designed to predict and analyze spirometry values. These devices assess lung function by generating predicted reference values for forced expiratory volume (FEV₁), forced vital capacity (FVC), and other spirometry metrics, aiding in the diagnosis and monitoring of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD).

These devices are intended for use in clinical and research settings, including anesthesiology, and are supplied as software-based tools. They are classified under Device Class II (FDA) and comply with MDR (Medical Device Regulation) standards. The SpiroSphere series operates as standalone calculators, requiring no sterilization or single-use considerations, and are compatible with standard spirometry equipment. Authorized under FDA 510(k) clearance (K223629) and EU MDR, they are intended for predictive analysis only and do not replace clinical judgment.

This description and any FAQs above were generated automatically from registry data and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them.

Authorization Coverage (2 countries)

Regulatory Authorizations

European Union Active

MDR

United States Active

FDA_510K

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (2)

  • FDA 510(k) K223629 24 fields · synced Sep 18, 2026
  • EUDAMED 1 fields · synced May 18, 2026